ANTIMICROBIAL PROPHYLAXIS AMONG AFRICAN ADULTS ON ART: RESULTS OF A RANDOMIZED TRIAL
Before widespread antiretroviral therapy (ART) use in sub-Saharan Africa, studies demonstrated that daily trimethoprim-sulfamethoxazole (TS) prophylaxis reduced morbidity and mortality among HIV-infected adults, predominantly by preventing malaria and diarrhea in this population. Routine administration of TS prophylaxis has continued with expanded access to ART throughout sub-Saharan Africa. However, the public health benefit has not been…